CNSP CNS Pharmaceuticals, Inc.

Fundamentals / CIK 0001729427 / USD

CNS Pharmaceuticals, Inc. reported $18.06M in total assets and a net loss of $15.98M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNSP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$0$0$0-$17.63MFY 2018 Net Income: -$7.39M2018FY 2019 Net Income: -$3.88M2019FY 2020 Net Income: -$9.46M2020FY 2021 Net Income: -$14.50M2021FY 2022 Net Income: -$15.27M2022FY 2023 Net Income: -$18.85M2023FY 2024 Net Income: -$14.86M2024FY 2025 Net Income: -$15.85M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $9.77M $9.29M $14.10M $9.30M $9.81M $5.06M $1.85M $21K
Total Operating Expenses $15.99M $14.90M $18.87M $15.27M $14.49M $9.45M $3.83M $882K
Operating Income -$15.99M -$14.90M -$18.87M -$15.27M -$14.49M -$9.45M -$3.83M -$882K
EBITDA -$15.98M -$14.90M -$18.86M -$15.26M -$14.47M -$9.44M -$3.83M -$882K
Interest Income -- -- $28K $0 -- -- -- --
Interest Expense $15K $16K $14K $7.0K $9.3K $3.3K $26K $29K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$15.85M -$14.86M -$18.85M -$15.27M -$14.50M -$9.46M -$3.88M -$7.39M
Basic EPS -$35.75 -$466.89 -$55,209,333,733.49 -$6,189,975,990,396.16 -$273,360,536,583,472.84 -$9,443,363,991,065.42 -$4,638,845,469,295.30 -$11,597,113,673,238.24
Diluted EPS -$35.75 -$466.89 -$55,209,333,733.49 -$6,189,975,990,396.16 -$273,360,536,583,472.84 -$9,443,363,991,065.42 -$4,638,845,469,295.30 -$11,597,113,673,238.24
Basic Shares Outstanding 443.4K 31.8K 0 0 0 0 0 0
Diluted Shares Outstanding 443.4K 31.8K 0 0 0 0 0 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $890K $1.20M $3.54M $3.16M $2.20M $1.17M $3.24M $1.50M
Total Operating Expenses $2.67M $2.70M $4.98M $5.99M $3.25M $2.41M $4.34M $3.20M
Operating Income -$2.67M -$2.70M -$4.98M -$5.99M -$3.25M -$2.41M -$4.34M -$3.20M
EBITDA -$2.67M -$2.69M -$4.97M -$5.99M -$3.25M -$2.41M -$4.34M -$3.20M
Interest Expense $3.0K $4.0K $6.1K $2.2K $2.0K $4.0K $6.2K $2.8K
Net Income -$2.50M -$2.59M -$4.94M -$5.96M -$3.22M -$2.38M -$4.30M -$3.18M
Basic EPS -$0.24 -$0.38 -$7.30 -- -$5.76 -$6.42 -$18.93 --
Diluted EPS -$0.24 -$0.38 -$7.30 -- -$5.76 -$6.42 -$18.93 --
Basic Shares Outstanding 10.6M 6.8M 676.2K -- 558.9K 370.1K 227.2K --
Diluted Shares Outstanding 10.6M 6.8M 676.2K -- 558.9K 370.1K 227.2K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.20M $6.46M $549K $10.06M $5.00M $14.04M $7.24M $283K
Cash & Short-Term Investments $7.20M $6.46M $549K $10.06M $5.00M $14.04M $7.24M $283K
Total Current Assets $8.10M $8.66M $1.59M $12.56M $7.48M $15.50M $7.89M $588K
Property, Plant & Equipment, Net $18K $6.0K $4.9K $5.7K $16K $23K $18K $0
Total Non-Current Assets $521K $42K $110K $488K $1.28M $358K $18K $95K
Total Assets $8.62M $8.70M $1.70M $13.05M $8.76M $15.85M $7.91M $683K
Accounts Payable -- -- -- $3.68M $1.98M $946K $244K $128K
Short-Term Debt -- -- -- -- -- $482K -- --
Other Current Liabilities -- -- -- -- -- -- $0 $763K
Total Current Liabilities $4.10M $2.52M $6.13M $4.92M $2.59M $1.91M $311K $1.23M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $4.10M $2.52M $6.13M $4.92M $2.59M $1.91M $311K $1.23M
Total Debt (incl. Leases) -- -- -- -- -- $482K -- --
Common Stock $1.0K $118 $2 $1.6K $949 $24K $16K $13K
Retained Earnings -$100.3M -$84.42M -$69.57M -$50.72M -$35.44M -$20.95M -$11.49M -$7.61M
Total Stockholders' Equity $4.52M $6.18M -$4.43M $8.13M $6.16M $13.95M $7.60M -$549K
Total Equity $4.52M $6.18M -$4.43M $8.13M $6.16M $13.95M $7.60M -$549K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $17.21M $19.98M $2.95M $7.20M $9.86M $12.13M $13.05M $6.46M
Cash & Short-Term Investments $17.21M $19.98M $2.95M $7.20M $9.86M $12.13M $13.05M $6.46M
Total Current Assets $18.05M $21.92M $4.08M $8.10M $11.39M $14.14M $13.72M $8.66M
Property, Plant & Equipment, Net $14K $15K $22K $18K $3.1K $3.8K $4.9K $6.0K
Total Non-Current Assets $14K $15K $575K $521K $478K $370K $27K $42K
Total Assets $18.06M $21.94M $4.65M $8.62M $11.87M $14.51M $13.75M $8.70M
Total Current Liabilities $2.36M $3.74M $4.58M $4.10M $1.96M $1.38M $2.78M $2.52M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $2.36M $3.74M $4.58M $4.10M $1.96M $1.38M $2.78M $2.52M
Common Stock $2.0K $2.0K $811 $1.0K $574 $504 $2.9K $118
Retained Earnings -$110.3M -$107.8M -$105.2M -$100.3M -$94.32M -$91.10M -$88.73M -$84.42M
Total Stockholders' Equity $15.71M $18.20M $71K $4.52M $9.91M $13.12M $10.97M $6.18M
Total Equity $15.71M $18.20M $71K $4.52M $9.91M $13.12M $10.97M $6.18M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$15.85M -$14.86M -$18.85M -$15.27M -$14.50M -$9.46M -$3.88M -$7.39M
Depreciation & Amortization $3.9K $3.3K $4.1K $12K $13K $11K $2.0K $0
Stock-Based Compensation $188K $839K $1.01M $1.20M $1.72M $1.29M $477K $110K
Change in Payables -- -- -- $1.70M $1.04M $703K $109K $86K
Operating Cash Flow -$13.81M -$17.11M -$14.14M -$10.56M -$13.54M -$7.32M -$3.55M -$716K
Capital Expenditure -$18K -$4.2K -$3.9K -$4.4K -$5.7K -$18K -$20K $0
Free Cash Flow -$13.83M -$17.12M -$14.14M -$10.56M -$13.54M -$7.34M -$3.57M -$716K
Investing Cash Flow -$18K -$4.2K -$3.9K -$4.4K -$5.7K -$18K -$20K $0
Common Stock Issued $14.05M $23.38M $2.32M $16.04M $4.65M -- $10.29M $390K
Financing Cash Flow $14.57M $23.03M $4.64M $15.61M $4.51M $14.13M $10.26M $1.16M
Net Change in Cash $740K $5.91M -$9.51M $5.05M -$9.03M $6.80M $6.69M $445K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.50M -$2.59M -$4.94M -$5.96M -$3.22M -$2.38M -$4.30M -$3.18M
Depreciation & Amortization $0 $11K $1.9K $918 $1.0K $900 $1.1K $985
Stock-Based Compensation $25K $2.0K $2.6K $85K $19K $22K $62K $130K
Operating Cash Flow -$2.77M -$3.54M -$4.65M -$3.05M -$2.17M -$5.34M -$3.24M -$5.47M
Capital Expenditure $0 -$3.8K -$6.2K -$18K $0 $0 $0 --
Free Cash Flow -$2.77M -$3.54M -$4.65M -$3.07M -$2.17M -$5.34M -$3.24M --
Investing Cash Flow $0 -$3.8K -$6.2K -$18K $0 $0 $0 --
Common Stock Issued -- -- $501K -- -- -- $9.03M $5.00M
Financing Cash Flow $0 $20.58M $405K $407K -$92K $4.43M $9.83M $4.96M
Net Change in Cash -$2.77M $17.03M -$4.25M -$2.66M -$2.27M -$918K $6.59M -$512K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -350.4% -240.5% -- -187.8% -235.2% -67.8% -51.0% --
Return on Assets (ROA) -183.8% -170.8% -1108.3% -117.0% -165.5% -59.7% -49.0% -1081.7%
Current Ratio 1.98x 3.43x 0.26x 2.55x 2.88x 8.13x 25.38x 0.48x
Quick Ratio 1.76x 2.56x 0.09x 2.04x 1.93x 7.37x 23.28x 0.23x
Debt to Equity -- -- -- -- -- 0.03x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -101.7% -91.8% -23219.1% -350.4% -131.9% -117.8% -142.3% -240.5%
Return on Assets (ROA) -88.5% -76.1% -354.3% -183.8% -110.1% -106.6% -113.6% -170.8%
Current Ratio 7.65x 5.86x 0.89x 1.98x 5.81x 10.22x 4.94x 3.43x
Quick Ratio 7.30x 5.35x 0.64x 1.76x 5.03x 8.77x 4.69x 2.56x
Source: SEC EDGAR CompanyFacts (CIK 0001729427) · from March 31, 2018 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal